Jump to content

Myocardiodystrophy

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Addbot (talk | contribs) at 03:24, 20 February 2013 (Bot: Migrating 2 interwiki links, now provided by Wikidata on d:q4295389 (Report Errors)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Myocardiodystrophy is a type of noninflammatory heart disease that affects the myocardium. It is characterized by cardiac pain that occurs in the morning and that cannot be stopped even with normal treatments of nitroglycerin, along with other occurrences of heart rhythm disturbances, dyspnea, and various types of heart failure.[1][2]

Etiology

There are multiple originations for myocardiodystrophy. Alcohol intoxication can originate the creation of it, along with making it worse if consumption continues over a long period of time. Different types of obesity can also originate the disease,[3] along with other endocrine diseases, infections, and various types of neurological pathologies.[1]

References

  1. ^ a b Myocardiodystrophy on CALMED[unreliable medical source?]
  2. ^ Dorofeyeva EE, Dorofeyev AE (2004). "Biochemical and heart adaptations to physical training and supplementation with amino acids". Journal of Strength and Conditioning Research. 18 (4): 738–40. doi:10.1519/12922.1. PMID 15574076. {{cite journal}}: Unknown parameter |month= ignored (help)
  3. ^ Sinitsyn PD, Kholodova EA (1983). "[Diagnosis and pathogenesis of diabetic myocardiodystrophy]". Kardiologiia (in Russian). 23 (10): 35–8. PMID 6645168. {{cite journal}}: Unknown parameter |month= ignored (help)

Further reading

  • Gnatiuk MS, Slivka IuI, Gnatiuk LA (1998). "[Secretory activity of atrial cardiomyocytes in adrenaline myocardiodystrophy]". Patologicheskaia Fiziologiia I Èksperimental'naia Terapiia (in Russian) (2): 36–7. PMID 9633198.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Temirova KV, Kurlygina LA, Zavodskaia IS, Novikova NA (1976). "[Energy metabolism and myocardial function in myocardiodystrophy]". Kardiologiia (in Russian). 16 (9): 98–102. PMID 1011536. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  • Tret'iakov SV, Loseva MI, Shpagina LA (1997). "[The characteristics of cardiac diastolic function in myocardiodystrophy in persons subjected to aromatic hydrocarbon exposure]". Terapevticheskiĭ Arkhiv (in Russian). 69 (1): 47–9. PMID 9163050.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Iakimenko-Vasiutina EA (1990). "[The treatment of women with dyshormonal myocardiodystrophy]". Vrachebnoe Delo (in Russian) (8): 65–7. PMID 2256296. {{cite journal}}: Unknown parameter |month= ignored (help)
  • Eliseev, V. E.; Slobodskaya, V. V.; Il'in, G. I.; Kostin, É. D. (1985). "Influence of Riboxine, uridine, uridine-5'-monophosphate, and guanosine on experimental myocardial dystrophy" ([dead link]). Pharmaceutical Chemistry Journal. 19 (6): 406–8. doi:10.1007/BF00766947.
  • Goncharova EV, Govorin AV (2008). "[Changes in fatty acids content in blood red cells of patients with iron-deficiency anemia treated with sorbifer and mildronate]". Terapevticheskiĭ Arkhiv (in Russian). 80 (6): 65–8. PMID 18655480.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Myocardiodystrophy&oldid=539164840"